Chlorophyllin for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Chlorophyllin for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A water-soluble, copper-carrying form of the green plant pigment. One action is well supported: it grips certain flat cancer-causing molecules in the gut so fewer are absorbed. The odor claim failed controlled testing. Stool and urine turn green to black, a few users developed lasting sun sensitivity, and the copper it carries is unmeasured in long-term users. (Full Review)

Protocol

Standard interception schedule
100 mg three times daily
Sodium copper chlorophyllin, immediately before or with meals; the only oral regimen with randomized human biomarker data behind it.
Non-prescription deodorant schedule
100 to 200 mg daily
In divided doses, the range recognized in the United States over-the-counter internal deodorant monograph.
Alternative oncology schedule
750 mg once each morning
Before breakfast; the fasting high-dose approach used in radioprotection trials, and a deliberate departure from meal-tied dosing.
Time to effect
Carcinogen interception
Immediate
Meal-bound, with no loading period.
Biomarker change
3 to 4 months
The interval over which the chemoprevention trials measured change.
Odor change
1 to 2 weeks
Where it occurs at all.

Benefits

Contraindications
  • Wilson disease or any diagnosed copper-overload state
  • Cholestatic liver disease or cirrhosis at Child-Pugh Class C
  • Erythropoietic protoporphyria and the other light-triggered porphyrias
  • Previous chlorophyll-induced pseudoporphyria or unexplained blistering on sun-exposed skin
  • Pregnancy and lactation
  • Children
  • The seven days before guaiac-based stool blood testing
  • Copper chelators (penicillamine, trientine, zinc acetate for Wilson disease)
  • Photodynamic therapy, phototherapy, and tanning beds during treatment
    •
Key Interactions
  • Photosensitizing prescription drugs (doxycycline, ciprofloxacin, amiodarone, voriconazole, hydrochlorothiazide)
  • Over-the-counter photosensitizing anti-inflammatories (piroxicam, ketoprofen, naproxen)
  • Narrow-margin oral drugs with flat aromatic structures (levothyroxine, tetracyclines, quinolones, methotrexate)
  • Anticoagulants and antiplatelet drugs (warfarin, apixaban, aspirin)
  • Over-the-counter bismuth subsalicylate and iron tablets
  • Copper-containing multivitamins and mineral formulas
  • High-dose zinc (above 40 mg daily)
  • Additive binders (activated charcoal, bentonite clay, chlorella, cholestyramine)
  • St John's wort and high-dose riboflavin
    •

Risk & Side Effects

  • High: Green to black discoloration of stool, urine, and tongue
    •
  • Medium: Photosensitivity and blistering skin reactions; false-positive guaiac stool and gastric blood tests
  • Low: Copper load from the sodium copper form; gastrointestinal upset; local irritation from topical use
  • Speculative: Interception of co-ingested drugs and nutrients; loss of protection or tumor shielding outside the initiation window

Monitoring

Marker Target Why
Serum copper 80-100 µg/dL Detects copper loading from the sodium copper form
Ceruloplasmin 20-30 mg/dL Main copper carrier; distinguishes true overload from an inflammatory rise
Serum zinc 90-110 µg/dL Zinc falls as copper rises; flags imbalance before symptoms
Copper-to-zinc ratio 0.8-1.0 More sensitive to imbalance than either value alone
ALT and AST ALT below 20 U/L in men and below 17 U/L in women Liver stores copper first, and these enzymes rise before symptoms do
Ferritin 50-100 ng/mL Baseline iron stores before any use of the iron-containing form
Complete blood count Track change from the individual's own baseline Low white counts are both a claimed indication and a copper-deficiency sign
Fecal immunochemical test Negative Colorectal screening that the green pigment cannot disturb
24-hour urinary copper Track change from the individual's own baseline Rises earlier than serum copper when excretion capacity is exceeded

Cadence: Baseline panel before starting, then retesting at 3 months, at 6 months, and every 6 to 12 months for as long as use continues; brought forward immediately if new sun sensitivity, unexplained fatigue, or abdominal discomfort appears.

Qualitative Assessment

  • Skin response to sunlight, recorded as time to burning or stinging compared with the pre-supplement baseline
  • Presence of any new blistering, fragility, or scarring on the backs of the hands and forearms
  • Odor change, where odor was the reason for use, rated on a simple daily scale by a consistent observer
  • Stool and urine color, tracked as a marker of adherence rather than of benefit
  • Digestive comfort, specifically stool looseness and cramping in the hours after each dose
  • Energy and general wellbeing, to catch the fatigue that precedes measurable copper-related liver change
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.